Cargando…
Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options
INTRODUCTION: Hospital-acquired infections (HAIs) and growing antimicrobial resistance (AMR) represent a significant healthcare burden globally. Especially in Greece, HAIs with limited treatment options (LTO) pose a serious threat due to increased morbidity and mortality. This study aimed to estimat...
Autores principales: | Barmpouni, Myrto, Gordon, Jason P., Miller, Ryan L., Pritchard, Clive R. J., Dennis, James W., Grammelis, Vassilis, Rousakis, Aris, Souliotis, Kyriakos, Poulakou, Garyphallia, Daikos, George L., Al-Taie, Amer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770558/ https://www.ncbi.nlm.nih.gov/pubmed/36544074 http://dx.doi.org/10.1007/s40121-022-00743-4 |
Ejemplares similares
-
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece
por: Barmpouni, Myrto, et al.
Publicado: (2023) -
Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants
por: Warren, Sophie, et al.
Publicado: (2023) -
Less contact isolation is more in the ICU: pro
por: Poulakou, Garyphallia, et al.
Publicado: (2020) -
Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study
por: Matsumoto, Tetsuya, et al.
Publicado: (2022) -
COVID-19 Vaccination and Mental Health Outcomes among Greek Adults in 2021: Preliminary Evidence
por: Souliotis, Kyriakos, et al.
Publicado: (2022)